Usability, Adherence and Diagnostic Performance of PointCheck in Pediatric Population

CompletedOBSERVATIONAL
Enrollment

46

Participants

Timeline

Start Date

September 7, 2021

Primary Completion Date

July 31, 2023

Study Completion Date

July 31, 2023

Conditions
Hematologic Malignancy
Interventions
DEVICE

PointCheck

PointCheckTM is intended for use to aid in the assessment of severe neutropenia in the home or clinic setting in subjects receiving myelosuppressive chemotherapy with intermediate to high febrile neutropenia risk. The device non-invasively captures real-time videos of blood flow in the nailfold microcirculation and utilizes visible light, a microscope and a computer vision software to provide a qualitative result. The device is limited to use as a preliminary assessment tool in conjunction with standard of care, including temperature monitoring and clinical assessment. It is not to be used as a stand-alone determinant of severe neutropenia or for any other diagnostic purpose

Trial Locations (1)

77030

MD Anderson Cancer Center, Houston

All Listed Sponsors
collaborator

M.D. Anderson Cancer Center

OTHER

collaborator

Center for Advancing Point of Care Technologies

OTHER

lead

Leuko Labs, Inc.

INDUSTRY

NCT04889937 - Usability, Adherence and Diagnostic Performance of PointCheck in Pediatric Population | Biotech Hunter | Biotech Hunter